Cargando…
Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice
BACKGROUND: Inhibin is a tumor-suppressor and activin antagonist. Inhibin-deficient mice develop gonadal tumors and a cachexia wasting syndrome due to enhanced activin signaling. Because activins signal through SMAD2 and SMAD3 in vitro and loss of SMAD3 attenuates ovarian tumor development in inhibi...
Autores principales: | Rajanahally, Saneal, Agno, Julio E, Nalam, Roopa L, Weinstein, Michael B, Loveland, Kate L, Matzuk, Martin M, Li, Qinglei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903601/ https://www.ncbi.nlm.nih.gov/pubmed/20565978 http://dx.doi.org/10.1186/1477-7827-8-69 |
Ejemplares similares
-
Absence of Inhibin Alpha and Retinoblastoma Protein Leads to Early Sertoli Cell Dysfunction
por: Nalam, Roopa L., et al.
Publicado: (2010) -
Appetite for reproduction: dietary restriction, aging and the mammalian gonad
por: Nalam, Roopa L, et al.
Publicado: (2008) -
Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer
por: Kriseman, Maya, et al.
Publicado: (2019) -
The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction
por: Gross-Tsur, Varda, et al.
Publicado: (2012) -
Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis
por: Monsivais, Diana, et al.
Publicado: (2021)